Share
Publications
-
12 November 2012 /Prices and reimbursement
-
07 December 2012 /Product areas
Annual report human on tissues and cells 2011
The annual report for human tissues and cells for 2011 has been prepared pursuant to the Danish Tissue Act and is based on reports submitted by tissue establishments and gynaecology clinics in Denmark in the period January to December 2011.
-
01 August 2012 /Side effects and trials
Danish Medicines Agency's annual pharmacovigilance report 2011
The annual pharmacovigilance report offers an insight into some of the pharmacovigilance work performed by the Danish Medicines Agency in 2011.
-
31 January 2012 /Side effects and trials
Long-term treatment of osteoporosis patients with bisphosphonates
At present, there is very limited knowledge about long-term treatment with bisphosphonates for osteoporosis patients. But over the past years, reports suggestive of long-term adverse reactions have been submitted, e.g. osteonecrosis of the jaw and atypical fractures.
-
25 January 2012 /Prices and reimbursement
Monitor the trends in consumption of drugs for acid-related disorders
The Danish Medicines Agency monitors the consumption of drugs for acid-related disorders (drugs for heartburn, sour eructation and ulcer) in connection with the removal of the reimbursement for a number of these drugs on 15 November 2010.
-
02 March 2012 /Prices and reimbursement
Number of applications for individual reimbursement of medicines in 2011
In 2011, the Danish Medicines Agency (now the Danish National Board of Health) reviewed approx. 103,000 applications for single reimbursement (about 7 % more than in 2010), approx. 26,000 applications for reimbursement for the chronically ill (about 30 % less than in 2010), approx. 12,000 applications for reimbursement for the terminally ill (about 3 % more than in 2010) and approx. 2,500 applications for increased reimbursement (about 12 % less than in 2010), cf. table 1.
-
26 November 2012 /Authorisation and supervision
Product defects and withdrawal of medicines 2011
In 2011, 356 reports of medicinal product defects were registered, which is the highest number ever. The majority of the reports came from companies and other authorities and predominantly concerned defects on the package and packaging material and deviations from specifications.
-
12 November 2012 /Retail and online sale
